Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

ALT-711 reduces left ventricular mass in DIAMOND trial

Jan. 23, 2003

HMR-1556 potently and selectively blocks the slowly activating delayed rectifier K+ current

Jan. 22, 2003

ANDROMEDA trial discontinued due to safety concerns

Jan. 22, 2003

Biprel launched in Canada for hypertension

Jan. 21, 2003

Ranexa terminates ventricular tachycardia in preclinical study

Jan. 21, 2003

Sex differences for NO-induced effects in sickle cell disease

Jan. 21, 2003

Clinical benefits induced by celecoxib in coronary artery disease

Jan. 20, 2003

Miravant presents novel porphyrins for the diagnosis and treatment of vascular disorders

Jan. 20, 2003

Miravant claims metalloporphyrin photosensitizers for cardiovascular PDT

Jan. 17, 2003

Phase II trial of MC-1 meets primary and secondary endpoints

Jan. 16, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...